4th Annual Summit: Biomarkers - CDx - Precision Immunotherapy
Hilton Garden Inn Vienna South, Hertha-Firnberg-Straße 5, 1100 Vienna (October, 4 – 5, 2018)
This premier B2B event provides the appropriate platform for participants
to engage with and discuss ideas with their fellow peers, while facilitating a professional atmosphere and environment for excellent company representation and development.
The Summit will shed light on current challenges, best practices,and the inside view of the future of precision diagnostics & Immunotherapy. We will discuss key findings, critical insights, and recommendations for driving efficient strategies in the diagnostics & immunotherapy landscape.
It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in coming October!
Key Practical Learning Points of the Summit:
-
Clinical & translational biomarkers in oncology and beyond
-
CDx development & regulatory
-
Dx market access, reimbursement, commercialization, partnerships
-
Precision Dx & personalized immunotherapy
Who Should Attend:
Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, and Managers specialising in
- Companion Diagnostics
- Molecular Diagnostics
- Personalised Healthcare
- Biomarkers
- Medical Sciences
- Experimental Medicine
- Translational Medicine
- Clinical Development
- Clinical Trials
- Regulatory
- Commercialisation
- Market Access
- Payers
- Patient Advocates
- Insurers
- Genomics
- Immunology
- Oncology
- Non-oncology
- Rare Diseases
- Drug Development Research
More: http://vonlanthengroup.com/en/events/4th-annual-cdx-biomarkers-precisi
